We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy. A SWENOTECA study.
- Authors
Tandstad, T; Cohn-Cedermark, G; Dahl, O; Stierner, U; Cavallin-Stahl, E; Bremnes, R M; Klepp, O
- Abstract
To offer minimized risk-adapted adjuvant treatment on a community and nationwide basis for patients with clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT). The aim was to reduce the risk of relapse and thereby reducing the need of later salvage chemotherapy while maintaining a high cure rate.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Vol 21, Issue 9, p1858
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdq026